Kimberly-Clark Co. (NYSE:KMB) Shares Sold by Prio Wealth Limited Partnership

Prio Wealth Limited Partnership trimmed its stake in Kimberly-Clark Co. (NYSE:KMB) by 2.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 16,390 shares of the company’s stock after selling 415 shares during the quarter. Prio Wealth Limited Partnership’s holdings in Kimberly-Clark were worth $2,265,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in KMB. Price T Rowe Associates Inc. MD increased its stake in Kimberly-Clark by 19.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock worth $762,279,000 after purchasing an additional 944,920 shares in the last quarter. Wulff Hansen & CO. lifted its holdings in Kimberly-Clark by 13,720.0% in the 2nd quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock worth $88,659,000 after purchasing an additional 636,882 shares during the last quarter. Marshall Wace LLP lifted its holdings in Kimberly-Clark by 48.4% in the 2nd quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after purchasing an additional 503,839 shares during the last quarter. Capital World Investors lifted its holdings in shares of Kimberly-Clark by 23.8% during the fourth quarter. Capital World Investors now owns 1,926,702 shares of the company’s stock worth $234,114,000 after buying an additional 370,094 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Kimberly-Clark by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock worth $267,383,000 after buying an additional 354,501 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Trading Up 0.1 %

NYSE:KMB opened at $142.44 on Wednesday. Kimberly-Clark Co. has a 52 week low of $116.32 and a 52 week high of $149.30. The company’s 50 day moving average price is $142.26 and its 200-day moving average price is $136.96. The stock has a market cap of $47.96 billion, a price-to-earnings ratio of 26.18, a PEG ratio of 3.00 and a beta of 0.39. The company has a quick ratio of 0.58, a current ratio of 0.85 and a debt-to-equity ratio of 5.59.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.25. The business had revenue of $5.03 billion during the quarter, compared to analyst estimates of $5.10 billion. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The company’s revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.65 earnings per share. On average, equities research analysts forecast that Kimberly-Clark Co. will post 7.25 earnings per share for the current fiscal year.

Kimberly-Clark Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 2nd. Investors of record on Friday, September 6th will be issued a dividend of $1.22 per share. The ex-dividend date is Friday, September 6th. This represents a $4.88 dividend on an annualized basis and a yield of 3.43%. Kimberly-Clark’s payout ratio is 89.71%.

Analyst Ratings Changes

A number of analysts have weighed in on KMB shares. BNP Paribas assumed coverage on Kimberly-Clark in a research report on Monday, June 24th. They issued a “neutral” rating and a $146.00 price target on the stock. Bank of America upgraded shares of Kimberly-Clark from an “underperform” rating to a “buy” rating and raised their price objective for the stock from $115.00 to $160.00 in a report on Thursday, June 13th. JPMorgan Chase & Co. upped their target price on Kimberly-Clark from $123.00 to $135.00 and gave the stock an “underweight” rating in a report on Monday, July 22nd. TD Cowen started coverage on shares of Kimberly-Clark in a report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 target price on the stock. Finally, Argus upgraded shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Kimberly-Clark currently has a consensus rating of “Hold” and a consensus price target of $145.67.

Insider Buying and Selling

In related news, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the sale, the insider now directly owns 7,377 shares in the company, valued at approximately $1,038,976.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Gonzalo Uribe sold 1,780 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the sale, the insider now owns 7,377 shares in the company, valued at $1,038,976.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $141.42, for a total value of $5,331,392.58. Following the sale, the insider now directly owns 19,935 shares of the company’s stock, valued at approximately $2,819,207.70. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.